Results 201 to 210 of about 19,473,068 (392)

Sintering and related phenomena-Materials Science Research Seriesedited by G. C. Kuczynski [PDF]

, 1973
M. M. Woolfson
openalex   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Retracted: Effect of Tool Profile Influence in Dissimilar Friction Stir Welding of Aluminium Alloys (AA5083 and AA7068)

Advances in Materials Science and Engineering, 2023
Advances in Materials Science and Engineering
doaj   +1 more source

Cavitation Damage and Crystal Structure (A Study of Cavitation Damage from the Viewpoint of Material Science, III)

, 1966
Nobumitsu Kitashima
openalex   +2 more sources

Electron microscopy in material scienceedited by U. Valdré [PDF]

, 1973
Andre Chambers
openalex   +1 more source

Materials science approaches in the development of broad-spectrum antiviral therapies

Nature Materials, 2020
Nam‐Joon Cho, Jeffrey S. Glenn
semanticscholar   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Retracted: Nanoscale Characterization and Impurities of Fused Silica Optical Surfaces

Advances in Materials Science and Engineering, 2023
Advances in Materials Science and Engineering
doaj   +1 more source

Materials Science and Engineering [PDF]

, 1974
openaire   +2 more sources

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source